ES2193303T3 - Procedimiento para la preparacion de plasma deficitario en factor v, y un plasma deficitario asi obtenido. - Google Patents

Procedimiento para la preparacion de plasma deficitario en factor v, y un plasma deficitario asi obtenido.

Info

Publication number
ES2193303T3
ES2193303T3 ES97112829T ES97112829T ES2193303T3 ES 2193303 T3 ES2193303 T3 ES 2193303T3 ES 97112829 T ES97112829 T ES 97112829T ES 97112829 T ES97112829 T ES 97112829T ES 2193303 T3 ES2193303 T3 ES 2193303T3
Authority
ES
Spain
Prior art keywords
factor
plasma
deficit
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97112829T
Other languages
English (en)
Inventor
Michael Dr Kraus
Erika Aillaud
Heinz-Hermann Drescher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg GmbH filed Critical Dade Behring Marburg GmbH
Application granted granted Critical
Publication of ES2193303T3 publication Critical patent/ES2193303T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96463—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

LA INVENCION TRATA DE UN PROCEDIMIENTO PARA FABRICAR PLASMAS CARENCIALES, EN ESPECIAL UN PLASMA CARENCIAL DE FACTOR V A PARTIR DE UN PLASMA DE PARTIDA, EMPLEANDO ANTICUERPOS.
ES97112829T 1996-08-24 1997-07-25 Procedimiento para la preparacion de plasma deficitario en factor v, y un plasma deficitario asi obtenido. Expired - Lifetime ES2193303T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19634312A DE19634312A1 (de) 1996-08-24 1996-08-24 Verfahren zur Herstellung von Faktor V-Mangelplasma und ein so erhaltenes Mangelplasma

Publications (1)

Publication Number Publication Date
ES2193303T3 true ES2193303T3 (es) 2003-11-01

Family

ID=7803630

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97112829T Expired - Lifetime ES2193303T3 (es) 1996-08-24 1997-07-25 Procedimiento para la preparacion de plasma deficitario en factor v, y un plasma deficitario asi obtenido.

Country Status (7)

Country Link
US (1) US6211344B1 (es)
EP (1) EP0826965B1 (es)
JP (1) JP4313443B2 (es)
AT (1) ATE239231T1 (es)
CA (1) CA2213742C (es)
DE (2) DE19634312A1 (es)
ES (1) ES2193303T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855509B2 (en) * 2000-12-19 2005-02-15 Instrumentation Laboratory Company Protein S functional assay and kit therefor
JP4468302B2 (ja) * 2003-09-12 2010-05-26 日鉱金属株式会社 スパッタリングターゲット及び同ターゲットの表面仕上げ方法
US20060068454A1 (en) * 2004-09-27 2006-03-30 Sysmex Corporation Method of inactivating blood coagulation factor and blood coagulation factor-inactivated sample
JP4671823B2 (ja) * 2004-09-27 2011-04-20 シスメックス株式会社 血液凝固因子の不活化方法及び血液凝固因子不活化試料
FR2910969B1 (fr) * 2006-12-29 2009-02-27 Lab Francais Du Fractionnement Procede de mesure de la concentration de facteur viia (fviia) dans un echantillon
DE102009048199A1 (de) 2009-10-05 2011-04-21 Siemens Healthcare Diagnostics Products Gmbh Verfahren zur Bestimmung von Faktor XIII mit Hilfe von Referenzmaterial auf Plasmabasis
JP5839256B2 (ja) * 2011-03-14 2016-01-06 学校法人九州文化学園 総プロテインｓ異常症の検出方法において用いる試薬

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE419871B (sv) * 1975-12-01 1981-08-31 Pharmacia Ab Sett att bestemma aktiviteten hos faktor xa-inhibitor i blod
DE3707213A1 (de) * 1987-03-06 1988-09-15 Behringwerke Ag Verfahren zur herstellung von faktor viii:c-mangelplasma und ein so erhaltenes mangelplasma
US5049491A (en) * 1987-11-19 1991-09-17 The University Of Vermont Immunologic detection of factor V(VA) fragments in hemorrhagic and thrombotic clinical settings
US7169572B1 (en) * 1993-01-29 2007-01-30 T.A.C. Thrombosis And Coagulation Ab Assays for determining anticoagulant cofactor activity
JPH08510555A (ja) * 1993-07-01 1996-11-05 デイド、インターナショナル、インコーポレイテッド 第ｘ因子除去血漿の調製のための方法
ES2154703T5 (es) 1994-11-10 2008-02-01 Dade Behring Marburg Gmbh Procedimiento para la deteccion especifica de un factor de coagulacion v activado con una estabilidad elevada frente a proteina c activada.
US5705395A (en) * 1994-11-14 1998-01-06 The Scripps Research Institute Method for diagnosis of thrombotic disorders

Also Published As

Publication number Publication date
JPH1067668A (ja) 1998-03-10
DE19634312A1 (de) 1998-02-26
ATE239231T1 (de) 2003-05-15
CA2213742A1 (en) 1998-02-24
JP4313443B2 (ja) 2009-08-12
EP0826965B1 (de) 2003-05-02
CA2213742C (en) 2007-10-30
EP0826965A1 (de) 1998-03-04
US6211344B1 (en) 2001-04-03
DE59709955D1 (de) 2003-06-05

Similar Documents

Publication Publication Date Title
ATE21932T1 (de) Bispezifische antikoerperdeterminanten.
CA2103059A1 (en) Method for making humanized antibodies
ES551496A0 (es) Procedimiento de obtencion de un anticuerpo monoclonal reactivo con antigenos de esporozoitos de eimeria spp.
IL139419A0 (en) Monoclonal antibodies, cross-reactive antibodies and method for producing the same
ES551495A0 (es) Procedimiento de obtencion de un anticuerpo monoclonal reactivo con antigenos de esporozoitos o merozoitos de eimeria spp.
DE3480494D1 (en) Method and reagent for use in the assay of pivka-ii
ES2057307T3 (es) Anticuerpo monoclonal anti-nucleo beta de hcg, su produccion y su uso.
DK0709455T3 (da) Monoklonalt antistof med humanglicentin, hybridoma til fremstilling af antistoffet og assaymetode for humanglicentin ved an
CA2012264A1 (en) Anti-human sperm antibody and its production and use
ES2056919T3 (es) Anticuerpo monoclonal especifico para la fosfolipasa a2 pancreatica humana.
DE59709955D1 (de) Verfahren zur Herstellung von Faktor V-Mangelplasma und ein so erhaltenes Mangelplasma
ES2061973T3 (es) Anticuerpos monoclonales que reconocen la region n-terminal de polipeptido natriuretico auricular, su preparacion y uso.
DK0459450T3 (da) Monoklonalt antistof, som genkender membran-phospholipase A2 og immunobestemmelse af membran-phospho liphase A2
ES2061664T3 (es) Anticuerpos monoclonales que reconocen a alfa-hanp y correspondientes hibridomas, su preparacion y uso.
DK329789D0 (da) Monoklonalt antistof
EP0922761A4 (en) MONOCLONAL ANTIBODY, SPECIFIC FOR ANTI-HUMAN FIBRINE MONOMER, METHOD FOR PRODUCING THE SAME, HYBRYDOM CELLS AND AN IMMUNOASSAY METHOD
EP0369797A3 (en) A monoclonal antibody recognizing a reg protein
GR3022544T3 (en) Monoclonal antibodies to leptosphaeria
AU8819391A (en) Antibody reactive to hamster immunoglobulins
FI893427A7 (fi) Monoklonaalinen vasta-aine, joka pystyy tunnistamaan gangliosideja GQ1b ja GT1a, sitä tuottava hybridooma sekä menetelmä hybridooman valmistamiseksi
ES2059726T3 (es) Anticuerpos monoclonales que reconocen el itsp humano, hibridomas que producen los mismos, y su preparacion y uso.
AU1020795A (en) Monoclonal antibodies to mycosphaerella species
BR1101137KB1 (pt) método para a produção de anticorpos humanizados.
AU4955593A (en) Peptide showing cross-reactivity with the anti-hepatitis b surface antigen antiserum